Stem Cell Clinic

Genfit throws in the towel on NASH, exiting a tumultuous field full of bright market prospects and lethal R&D setbacks – Endpoints News

By Stem Cell Medicine

Bob Nelsen had been quietly wondering how to eradicate viruses for years, before one day in 2015, he welcomed a pair of immunologists into the ARCH Venture Partners offices on the 34th floor of Seattles Wells Fargo Building.

Louis Picker and Klaus Frh, professors at Oregon Health & Science University, had by then spent 5 years running around the country in search of funding for their startup, TomegaVax, and Frh, at least, was nearing wits end. The Gates Foundation was interested but told them they needed other investors. Investors told them to come back with more data, pharmaceutical executives said theyre in the wrong game too little money to be made fighting infectious disease. Still, a well-connected board member named Bob More landed them a meeting with the coveted venture capitalist, and so, in a narrow conference room overlooking the Puget Sound, Picker prepared to again explain the idea he had spent 15 years on: re-engineering a benign microbe into the first vaccines for HIV and better ones for hepatitis and tuberculosis.

This lightbulb went on his head, Picker recalled in a recent interview. Most of them just didnt get it. And Bobs hit.

By that point, Nelsen was more than just a venture capitalist. Scraggly and greying but no less opinionated at 52, he was mobbed at biotech conferences, having earned a reputation for crass wisdom and uncanny foresight, for making big bets on big ideas that changed medicine. Those ideas included DNA sequencing, which he first cut a check for in the 90s, and leveraging the immune system to tackle cancer. He earned millions making billion-dollar companies.

Yet for years he had harbored an almost singular obsession: I hate viruses, he told Forbes in 2016. He told me he was pissed off at them. The obsession drove him to his first biotech investment in 1993, for an inhalable flu vaccine approved a decade later and still in use. And it drove him to invest in CAR-T as a potential cure for HIV, years before it proved a wildly effective treatment for some cancers.

Now, listening to Picker talk about T cells and antibodies and the curious biology of cytomegalovirus, Nelsen began wondering if it was time for another bet. Pickers technology was not only promising, he reasoned, it could be the basis of a company that changed how researchers approached viruses. Instead of trying to come up with an antidote for every pathogen, you could do what cancer researchers had learned to do, and harness the immune system to do the work for you.

This wasnt a popular opinion at the time. Its like the least trendy idea in the world, Nelsen told me. People would say, Why the hell are you going into infectious disease?

Unlock this article along with other benefits by subscribing to one of our paid plans.

SUBSCRIBE SIGN IN

Read the original post:
Genfit throws in the towel on NASH, exiting a tumultuous field full of bright market prospects and lethal R&D setbacks - Endpoints News

Cell Proliferation Kit Market Global Production, Growth, Share, Demand and Applications Forecast to 2027 – Owned

By Stell Cell Research

Cell Proliferation Kit Market

UpMarketResearch, 29-07-2020: The research report on the Cell Proliferation Kit Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data and compared it with the changing market situations. The report covers all the necessary information required by new entrants as well as the existing players to gain deeper insight.

Furthermore, the statistical survey in the report focuses on product specifications, costs, production capacities, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and a list of end-user industries have been studied systematically, along with the suppliers in this market. The product flow and distribution channel have also been presented in this research report.

Get a PDF Copy of the Sample Report for Free @ https://www.upmarketresearch.com/home/requested_sample/7038

The Major Manufacturers Covered in this Report: Biological Industries Thermo Fisher Scientific Sigma-Aldrich (Merck) BD Biosciences GE Healthcare PerkinElmer Millipoore (Merck) Bio-Rad Biotium Mindray Medical

The Research Study Focuses on:

By Types: Colorimetric Detection Method Fluorescent Detection Method Other

By Applications: Clinical Industrial & Applied Science Stem Cell Research

By Regions:

To get this report at incredible Discounts, visit @ https://www.upmarketresearch.com/home/request_for_discount/7038

The Cell Proliferation Kit Market Report Consists of the Following Points:

Make an Inquiry of the Cell Proliferation Kit Market Report @ https://www.upmarketresearch.com/home/enquiry_before_buying/7038

In conclusion, the Cell Proliferation Kit Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rate, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.

About UpMarketResearch: Up Market Research (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Contact Info UpMarketResearch Name Alex Mathews Email [emailprotected] Organization UpMarketResearch Address 500 East E Street, Ontario, CA 91764, United States.

Read the rest here:
Cell Proliferation Kit Market Global Production, Growth, Share, Demand and Applications Forecast to 2027 - Owned

R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico – Benzinga

By Stem Cell Treatment

SCOTTSDALE, Ariz., July 29, 2020 /PRNewswire-PRWeb/ -- R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

Several studies have shown just how well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with a long history of accreditation and pristine safety record. The lab abides by quality assurance standards that exceed those of the FDA.

Stem cell treatment for knees in Mexico at R3 works amazingly well. Patient satisfaction surveys at the center reveal that nine out of ten patients say they would have the procedure again and recommend it to friends and family.

According to R3 CEO David Greene, MD, MBA, "The biologics don't need preservative and viability exceeds 95%. The pureness and potency truly makes the difference in outcomes. Four joints for under $4000? What we put together for patients is incredible!"

The treatment process begins with a free phone consultation with one of R3's licensed, experienced stem cell doctors. Because the treatment includes 50 million stem cells, four joints may be included. The dedicated patient concierge representative assists with travel logistics. Travel from San Diego is included to the clinic, which is only 20 minutes from the San Diego airport.

Image guidance is used at the Center to ensure injection accuracy. In addition to arthritis treatment, R3 International offers stem cell treatment for autism, Lyme, COPD, kidney failure, neuropathy, diabetes, MS, ALS, stroke and much more.

Call (888) 988-0515 to learn more about therapies offered, and visit https://stemcelltreatmentclinic.com to read about the process.

SOURCE R3 Stem Cell International

See the rest here:
R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico - Benzinga

Global Stem Cell Therapy Market 2020: Growth, Demand, Service, Types, Applications, Key Players and Industry Forecast till 2025 – Bulletin Line

By Stem Cell Treatment

Global Stem Cell Therapy market report presents an overview of the market on the basis of key parameters such as market size, revenue, sales analysis and key drivers. The market size of global Stem Cell Therapy market is anticipated to grow at large scale over the forecast period (2020-2025). The main purpose of the study report is to give users an extensive viewpoint of the market. So that users can apply strategic processes to benchmark themselves against rest of the world. Key drivers as well as challenges of the market are discussed in the report. Also reports provides an in depth analysis of the Stem Cell Therapy market with current and future trends.

Get Sample Copy of this Report:https://www.adroitmarketresearch.com/contacts/request-sample/691

In addition, study report offers an array of opportunities for the players participating in the industry. This ultimately leads into the growth of the global Stem Cell Therapy market. Furthermore, report offers a comprehensive study on market size, revenue, sales, growth factors and risks involved in the growth of the market during the forecast period. The factors which are influencing the growth the market are mentioned in the report as well as the challenges which can hamper the growth of the market over the forecast period.

The main objective of this research report is to present the comprehensive analysis about the factors which are responsible for the growth of the global Stem Cell Therapy market. The study report covers all the recent developments and innovations in the market for a Stem Cell Therapy. The global keyword market is likely to provide insights for the major strategies which is also estimated to have an impact on the overall growth of the market. Several strategies such as the PESTEL analysis and SWOT analysis is also being covered for the global market. These strategies have an impact on the overall market.

Browse the complete report @https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market

Global Stem Cell Therapy market is segmented based by type, application and region.

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

The research report on global Stem Cell Therapy market ensures users to remain competitive in the market. Also report helps to identify the new innovations and developments by existing key players to increase the growth of the global Stem Cell Therapy market. Study report covers all the geographical regions where competitive landscape exists by the players such as North America, Europe, Latin America, Asia-Pacific and Middle East Africa. Thus report helps to identify the key growth countries and regions.

In addition, report presents quantitative as well as qualitative narration of global Stem Cell Therapy market. The research report is beneficial for educators, researchers, strategy managers, academic institutions and analysts. Thus report helps all types of users to identify the strategic initiatives so that they can understand how to expand the global Stem Cell Therapy market business across the globe for the product development. Moreover, research report provides in depth analysis of all the segments which can impact on the market growth.

For Any Query on the Stem Cell Therapy Market:https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX 75204, U.S.A Phone No.: USA: +1 972-362 -8199 / +91 9665341414

Continue reading here:
Global Stem Cell Therapy Market 2020: Growth, Demand, Service, Types, Applications, Key Players and Industry Forecast till 2025 - Bulletin Line

Platelet-Rich Plasma (PRP) Specialist – Farmington, NM …

By Platelet Rich Plasma Injections

What is PRP?

Platelet-rich plasma (PRP) is a regenerative medicine treatment that uses components of your own blood. Plasma is the liquid base of your blood that contains solid substances, including red cells, white cells, and platelets.

In addition to clotting blood, platelets contain proteins called growth factors that stimulate your bodys healing process. PRP has about 5-10 times more platelets than regular blood. When injected into an area of damaged tissue, PRP releases a flood of growth factors that promote healing.

Scientists are currently researching the effectiveness of PRP on various diseases and injuries. Existing research shows that PRP injections are more effective than other treatments, such as viscosupplementation, at reducing pain and symptoms in patients with osteoarthritis of the knee.

In addition to arthritis, the team at Orthopedic Associates PA may use PRP to speed up the healing process for a variety of conditions, including:

They use PRP therapy on many parts of the body, including the foot and ankle, knee, hip, shoulder, elbow, hand, and wrist.

While more research is needed to understand exactly how PRP works, clinical studies suggest that it provides several benefits in orthopedic applications, including:

PRP treatment can improve your quality of life and functional mobility while reducing the need for surgery and pain-relieving medications.

PRP therapy is an in-office treatment that doesnt require surgery, anesthesia, or risk of serious side effects. First, your provider at Orthopedic Associates PA draws a vial of blood, typically from your arm. They process the blood to obtain PRP.

Then, they inject the PRP into the area of injured or damaged tissue. The growth factors trigger a cascade of healing and tissue regeneration in the treatment area. Because inflammation is a natural part of this process, its normal to experience a temporary increase in swelling and pain for a few days.

To learn how PRP therapy can improve your quality of life, call Orthopedic Associates PA, or book an appointment online today.

Read more here:
Platelet-Rich Plasma (PRP) Specialist - Farmington, NM ...

Global Huntington’s Disease Treatment Market- Industry Analysis and Forecast (2019-2027)- By Drug Type, Treatment, End-Users, and Region. – Red &…

By Gene Therapy Clinics

The global Huntingtons disease treatment market was valued US$ 1.53 Bn in 2019 and is expected to reach 3.23 Bn by 2027, at a CAGR of 46.68% during a forecast period.

Market Introduction:

Huntingtons disease is a rare genetic condition that affects the brain and results in the degeneration of the nerve cells. It occurs between the age of 30 and 50 and worsens with time. The disorder usually becomes fatal after 20 years of its occurrence. The symptoms of the targeted disorder include depression, mood swings, amnesia, involuntary movement, and weight loss. It is associated with Parkinsons disease and Alzheimers as well as other health complications. Huntingtons disease can be diagnosed through CT scans and MRIs.

The report study has analyzed the revenue impact of COVID-19 pandemic on the sales revenue of market leaders, market followers, and disrupters in the report, and the same is reflected in our analysis.

Market Drivers and Restraints:

Growth and advancement in the treatment process and machinery used to treat such disease are the leading factors for market growth. On-going scientific research responsible for awareness about Huntingtons disease amongst the population is considered as one of the major factors driving the growth of Huntingtons disease therapeutics market. Medical needs across the globe are seeking the attention of scientists and researchers to develop a therapy for Huntingtons disease. Furthermore, high investment by the pharmaceutical companies involved in the R&D sector to develop innovative and curative drugs for the disease is fuelling the growth of the global HD treatment market as there is no proper treatment available. Besides, the presence of alternative therapies, including speech therapy, psychotherapy, and physiotherapy strongly contributed and increased the potential of the market growth for Huntingtons disease therapeutics.

However, due to the presence of stringent regulation and policies, the number of approved drugs is limited, hampering the availability of the drug in the market whereby, hindering the market growth in the coming years.

Huntingtons Disease Treatment Market Segment analysis:

Based on the drug type segment, tetrabenazine is expected to dominate the overall market demand in the coming forecast as it is the only drug approved by the US FDA for the treatment of chorea in Huntingtons disease. Tetrabenazine provides significant benefits in the treatment of chorea associated with HD. Health-care providers need to screen patients carefully before initiating treatment with this medication due to the adverse effects of tetrabenazine. In the future, additional long-term and comparative studies would be useful for further clarification of the role of tetrabenazine in the treatment of HD-associated chorea. According to IQVIA, US sales of tetrabenazine tablets 12.5 mg and 25 mg were ~$ 0.119 Bn in the year 2019, projected to show significant growth during the forecasted period.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/65831

Huntingtons Disease Treatment Market Regional Analysis:

Regionally, North America is expected to dominate Huntingtons disease treatment market, the US is the major contributor with a reported market share of ~ 65.59% in the base year and is estimated to show steady growth during the forecasted period. The on-going R&D activities and investment by pharmaceutical companies in the region are projected to run the innovation of highly effective and improved drugs for the treatment of Huntingtons disorder. Furthermore, advancement in technology and the presence of numerous vendors based on small and large sales are majorly participating to invest in this market will boost the market growth in the coming years.

On the other hand, Europe is expected to show substantial market growth owing to its economic stability. Europe is estimated to hold the second-largest share in the market owing to the growing aging population along with rising research and development activities aiming at Huntingtons disease in the region.

The objective of the report is to present a comprehensive analysis of the Global Huntingtons Disease Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

Recent Advances in the Treatment of Huntingtons Disease: Targeting DNA and RNA:

Recent developments in gene therapy, including antisense oligonucleotides, small interfering RNAs, and gene editing are bringing new hope to the Huntingtons community. This step is expected to contribute to the market growth on another level in terms of value.

The report also helps in understanding Global Huntingtons Disease Treatment Market dynamics, structure by analysing the market segments and project the Global Huntingtons Disease Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Huntingtons Disease Treatment Market make the report investors guide.

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/65831

Scope of Huntingtons Disease Treatment Market

Global Huntingtons Disease Treatment Market, By Drug Type

Tetrabenazine Antidepressants Antipsychotic Drugs Tranquilizers Others Global Huntingtons Disease Treatment Market, By Treatment

Symptomatic therapy Disease-modifying therapy Global Huntingtons Disease Treatment Market, By End-Users

Hospital Clinics Online Pharmacies Retail Pharmacies Others Global Huntingtons Disease Treatment Market, By Region

North America Europe Asia Pacific Latin America Middle East & Africa Key Players Operating the Huntingtons Disease Treatment Market

Alnylam Pharmaceuticals Inc AmpliPhi Biosciences Corp Ceregene Inc Lundbeck Prana Biotechnology Limited Teva Pharmaceutical Industries Ltd Cortex Pharmaceuticals Inc Vertex Pharmaceuticals Incorporated Auspex Pharmaceuticals SOM Biotech GlaxoSmithKline Siena Biotech Raptor Pharmaceutical Pfizer Palobiofarma Omeros Ipsen Valeant Pharmaceuticals International Inc

MAJOR TOC OF THE REPORT

Chapter One: Huntingtons Disease Treatment Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Huntingtons Disease Treatment Market Competition, by Players

Chapter Four: Global Huntingtons Disease Treatment Market Size by Regions

Chapter Five: North America Huntingtons Disease Treatment Revenue by Countries

Chapter Six: Europe Huntingtons Disease Treatment Revenue by Countries

Chapter Seven: Asia-Pacific Huntingtons Disease Treatment Revenue by Countries

Chapter Eight: South America Huntingtons Disease Treatment Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Huntingtons Disease Treatment by Countries

Chapter Ten: Global Huntingtons Disease Treatment Market Segment by Type

Chapter Eleven: Global Huntingtons Disease Treatment Market Segment by Application

Chapter Twelve: Global Huntingtons Disease Treatment Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Huntingtons Disease Treatment Market Report at: https://www.maximizemarketresearch.com/market-report/global-huntingtons-disease-treatment-market/65831/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Continued here:
Global Huntington's Disease Treatment Market- Industry Analysis and Forecast (2019-2027)- By Drug Type, Treatment, End-Users, and Region. - Red &...

Johnny Tabaie is proud to announce the most powerful Stem Cell Therapy – Press Release – Digital Journal

By Stem Cell Medical Center

Johnny The Healer aka Johnny Tabaie is proud to announce the most powerful Stem Cell Therapy. This is our newest addition to an already very powerful treatment method. Offering the most innovative holistic natural approach to healing the mind the body to soul.

Johnny Tabaie aka Johnny The Healer created The Holistic Sanctuary 10 years ago, he has taken by storm the holistic health movement by creating and pioneering this new paradigm of healing.

Treatments like Massage therapy, Reiki sessions, Kundalini Yoga, HBOT hyperbaric oxygen therapy chamber sessions, daily iv drips NAD+, Amino drips, O-Zone infusion therapy, Ayahuasca ceremonies, Ibogaine treatment, DMT sessions, Stem Cell treatment, holistic dentistry and much more.

The unique and carefully weaved holistic modalities create the most effective and innovative therapy protocols ever created to date. With 80% success rate, patients are not prescribed addictive or toxic medications, or undergo countless hours of talk therapy group therapy and psychobabble instead they are they receive 150 hours of holistic one on one in a four-week inpatient program.

Patients who suffer from depression, PTSD, anxiety, drug addiction, alcohol addiction, medication dependency all enroll to experience this life changing healing method.

The five-star reviews all over the Internet showcases to success, effectiveness and healing potential of Johnny Tabaies healing center.

Media Contact Company Name: Johnny The Healer Contact Person: Johnny Tabaie Email: Send Email Phone: +1-310-601-7805 City: Los Angeles State: CA Country: United States Website: http://www.johnnythehealer.com/

See the rest here:
Johnny Tabaie is proud to announce the most powerful Stem Cell Therapy - Press Release - Digital Journal

R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico – Yahoo Finance

By Stem Cell Doctors

R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

SCOTTSDALE, Ariz., July 29, 2020 /PRNewswire-PRWeb/ -- R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

Several studies have shown just how well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with a long history of accreditation and pristine safety record. The lab abides by quality assurance standards that exceed those of the FDA.

Stem cell treatment for knees in Mexico at R3 works amazingly well. Patient satisfaction surveys at the center reveal that nine out of ten patients say they would have the procedure again and recommend it to friends and family.

According to R3 CEO David Greene, MD, MBA, "The biologics don't need preservative and viability exceeds 95%. The pureness and potency truly makes the difference in outcomes. Four joints for under $4000? What we put together for patients is incredible!"

The treatment process begins with a free phone consultation with one of R3's licensed, experienced stem cell doctors. Because the treatment includes 50 million stem cells, four joints may be included. The dedicated patient concierge representative assists with travel logistics. Travel from San Diego is included to the clinic, which is only 20 minutes from the San Diego airport.

Image guidance is used at the Center to ensure injection accuracy. In addition to arthritis treatment, R3 International offers stem cell treatment for autism, Lyme, COPD, kidney failure, neuropathy, diabetes, MS, ALS, stroke and much more.

Call (888) 988-0515 to learn more about therapies offered, and visit https://stemcelltreatmentclinic.com to read about the process.

SOURCE R3 Stem Cell International

Excerpt from:
R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico - Yahoo Finance

UAE’s first bone marrow transplant patient tells of life-saving treatment – The National

By Stem Cell Doctors

The first patient in the UAE to undergo a bone-marrow transplant using stem cell technology has told of how the treatment saved his life.

Abdullah Nazir Ahmad Muhammad, an electrician from Pakistan, faced terminal decline when doctors put him forward for the ground breaking treatment.

After he began to vomit blood, the 49-year-old had blood cancer diagnosed in 2018. Doctors said his health had begun to rapidly deteriorate and his only option was to undergo an expensive bone marrow transplant.

"I didnt have money to get a transplant and the UAE sponsored my treatment. I am happy to be first one to undergo this transplant in the UAE. It wouldnt have been able to afford it in Pakistan, said the father-of-four, whose family live in the Khanewal district.

I didnt have money to get a transplant and the UAE sponsored my treatment. I am happy to be first one to undergo this transplant in the UAE

Abdullah Nazir Ahmad Muhammad

Mr Muhammad received his transplant on July 18 at Sheikh Khalifa Medical City with involvement of Abu Dhabi Stem Cells Centre the facility developing a stem cell treatment for Covid-19 patients.

The transplant procedure will bring hope to cancer patients in the UAE, who can now seek treatment closer to home to remain with family.

Known as regenerative medicine, stem cell therapy promotes the repair of abnormal or injured tissue using stem cells. Doctors can manipulate the cells into the type the patient needs and inject them where repair is necessary. The cells can be taken from a matching donor or harvested from the patient, treated, then reintroduced to the body.

The UAE has began to harness stem cell therapy in recent months to fight the coronavirus but this was the first time it was used in a transplant in the Emirates.

In Mr Muhammeds case, stem calls were harvested from his own blood and were reinjected into him after he underwent a short course of chemotherapy. This is called an autologous bone marrow transplant.

Dr Fatima Al Kaabi, executive director of the Abu Dhabi Bone Marrow Transplant Programme, described the treatment as a milestone for the UAE.

"Most of these cases travel abroad so, in the near future, we will be self sufficient and efficient to take care of our own with the highest calibre of medical care and international standards."

Dr Al Kaabi said that, to harvest the cells, Mr Muhammed was injected with a stimulant that prompted the stem cells to leave his bone marrow and enter his blood stream. His blood was drawn using a machine similar to one used in kidney dialysis to separate the plasma containing the stem cells from the blood.

The plasma was safely stored while Mr Muhammed underwent chemotherapy to wipe out the bone marrow and give way to the new cells, she said.

Mr Muhammed was kept in a sterile area for 10 to 15 days to prevent him from catching infections until the stem cells were returned to his body. The reintroduction of cells to his body took about 20 minutes.

Following the successful autologous bone marrow transplant, Abu Dhabi Stem Cells Centre aims to begin carrying out transplants from related donors.

For now only we are doing autologous transplants, where the patient and donor are the same person, but in the near future we will not only do related transplantation but more complicated ones where donors are not related to the patient, said Dr Yendry Ventura, general manager of the stem cell centre and director of Abu Dhabi Bone Marrow Transplant Programme.

Sheikh Khalifa Medical City and the Department of Health Abu Dhabi are working on a stem cell donor registry.

The next transplant is scheduled in a few weeks time with the centre aiming to perform 10 transplants before the related transplant programme and, eventually, a transplant programme for children.

We want to provide the people of UAE a programme that is not only comparable with any other programmes in the rest of the world but also offers customised and personalised treatment," Dr Ventura said.

Mr Muhammed, who has been in hospital since July 8, will be released in a few days and plans to return to Pakistan in October to see his family.

Updated: July 28, 2020 09:05 PM

See original here:
UAE's first bone marrow transplant patient tells of life-saving treatment - The National

From cancer through Covid, how one mother retained hope – Buffalo News

By Stem Cell Doctors

Even in March, when she learned she had Covid-19, she thought she would soon go home.

On the day of her release from Roswell, Melissa Fuller is greeted by her son Jacob.

Normally, said Dr. Philip McCarthy, director of Roswells transplant and cellular therapy program, shed have cleared the virus in two to three weeks, but because her immune system wasn't strong enough, it took what seemed like forever.

She was at the cancer center from late winter into summer. The staff, intensely aware of that journey, speaks of Melissa with affection and a touch of awe. In 2016, she was working in payroll at the Madison-Oneida BOCES when she went to the doctor for shoulder pain she thought was triggered by a torn rotator cuff.

The ache was radiating from a tumor. McCarthy said she had an especially aggressive form of multiple myeloma, acancer of the bone. Melissa would eventually go through a stem cell transplant at the SUNY Upstate University Medical Center in Syracuse that she hoped would roll back the disease.

The transplant didnt work. Her doctor at Upstate, an oncologist who became a friend, told her quietly that she was running out of options. She suggested Melissa look to Roswell and its CAR T-cell therapy, leading her to McCarthy, who moved quickly based on the dire nature of the risk.

His team injected Melissa with her own healthy T-cells to recognize and kill her cancer, treatments that continued throughout her stay in February. The process was a success, McCarthy said. Most of her cancer disappeared, offering the greatest hope her family had felt for years.

Continued here:
From cancer through Covid, how one mother retained hope - Buffalo News

→←